Answer
Animal data show salmeterol xinafoate is excreted in milk, and risk to a breastfed child cannot be excluded; whether to stop breastfeeding or discontinue/avoid Serevent therapy must be decided by weighing breastfeeding benefits for the child against treatment benefits for the woman.
Sources for this answer
- Serevent AccuhalerGlaxoSmithKline UK · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 29Document updated
Sources checked